Published in J Biol Chem on September 25, 1972
Phosphoenolpyruvate carboxylase from the crassulacean plant Bryophyllum fedtschenkoi Hamet et Perrier. Purification, molecular and kinetic properties. Biochem J (1978) 1.86
Systematic identification of allosteric protein-metabolite interactions that control enzyme activity in vivo. Nat Biotechnol (2013) 1.36
Dynamic dissociating homo-oligomers and the control of protein function. Arch Biochem Biophys (2011) 1.06
Ultrasensitive regulation of anapleurosis via allosteric activation of PEP carboxylase. Nat Chem Biol (2012) 1.04
Malate-Induced Hysteresis of Phosphoenolpyruvate Carboxylase from Crassula argentea. Plant Physiol (1989) 0.80
Conformational changes in aspartate transcarbamylase. I. Proteolysis of the intact enzyme. J Biol Chem (1968) 5.34
Mechanism of activation of human plasminogen by streptokinase. Presence of active center in streptokinase-plasminogen complex. J Biol Chem (1972) 1.74
Kinetics of activation of human plasminogen by different activator species at pH 7.4 and 37 degrees C. J Biol Chem (1980) 1.63
Change in antibody conformation induced by hapten. Proc Natl Acad Sci U S A (1965) 1.27
Quantitative determination of the binding of epsilon-aminocaproic acid to native plasminogen. J Biol Chem (1978) 1.22
The binding of tranexamic acid to native (Glu) and modified (Lys) human plasminogen and its effect on conformation. J Biol Chem (1979) 1.19
Functional properties of hemoglobin Kempsey. J Biol Chem (1974) 1.18
Physiological activation of the human fibrinolytic system. Isolation and characterization of human plasminogen variants, Chicago I and Chicago II. J Biol Chem (1979) 1.17
Content and characterization of plasminogen activators in human lung tumors and normal lung tissue. Cancer Res (1980) 1.17
Protein substrate conformation and proteolysis. Proc Natl Acad Sci U S A (1965) 1.16
Localization of plasminogen activators in human colon cancer by immunoperoxidase staining. Cancer Res (1985) 1.15
Comparison of some properties of native (Glu) and modified (Lys) human plasminogen. J Biol Chem (1978) 1.12
Hemoglobin Gun Hill: deletion of five amino acid residues and impaired heme-globin binding. Science (1967) 1.12
Plasminogen activator secretion of human tumors in short-term organ culture, including a comparison of primary and metastatic colon tumors. Cancer Res (1983) 1.07
Affinity chromatography of thymidine kinase from a rat colon adenocarcinoma. Prep Biochem (1976) 1.05
The role of hemostasis and fibrinolysis in the metastatic spread of cancer. Semin Thromb Hemost (1984) 1.02
Conformational changes in aspartate transcarbamylase. 3. A functional model for allosteric behavior. J Biol Chem (1971) 1.01
Plasminogen activator activity and composition in human breast cancer. Cancer Res (1982) 1.01
Possible gonadal mosaicism in a family with hemoglobin Köln. Johns Hopkins Med J (1980) 0.98
Plasminogen activator content of human colon tumors and normal mucosae: separation of enzymes and partial purification. J Natl Cancer Inst (1980) 0.97
Interference of active site specific reagents in plasminogen-streptokinase active site formation. Biochemistry (1984) 0.94
Plasminogen activator content and secretion in explants of neoplastic and benign human prostate tissues. Cancer Res (1984) 0.94
Human plasmin. Methods Enzymol (1981) 0.93
Ligand-induced conformational changes in ribonuclease. J Biol Chem (1968) 0.93
Interference with dimethylhydrazine induction of colon tumors in mice by epsilon-aminocaproic acid. Science (1982) 0.91
Demonstration of urokinase expression in cancer cells of colon adenocarcinomas by immunohistochemistry and in situ hybridization. Am J Pathol (1999) 0.89
Comparative activation kinetics of mammalian plasminogens. Biochim Biophys Acta (1983) 0.89
Steady state kinetics of activation of human and bovine plasminogens by streptokinase and its equimolar complexes with various activated forms of human plasminogen. J Biol Chem (1978) 0.89
Oxygen Transport. Science (1960) 0.88
Plasminogen activator content of neoplastic and benign human prostate tissues; fibrin augmentation of an activator activity. Int J Cancer (1981) 0.88
Activator activities of the transient forms of the human plasminogen-streptokinase complex during its proteolytic conversion to the stable activator complex. J Biol Chem (1976) 0.87
Esterase activities in the zymogen moiety of the streptokinase-plasminogen complex. J Biol Chem (1974) 0.86
Structure and formation of microplasmin. Proc Natl Acad Sci U S A (1987) 0.86
Urokinase-like plasminogen activators of unusually high molecular weight secreted by a cell line derived from a human lung cancer case. J Biol Chem (1982) 0.85
Comparison of the esterase and human plasminogen activator activities of various activated forms of human plasminogen and their equimolar streptokinase complexes. J Biol Chem (1977) 0.84
Conformational changes in aspartate transcarbamylase. II. Concerted or sequential mechanism? J Biol Chem (1969) 0.84
Kinetic analysis of covalent hybrid plasminogen activators: effect of CNBr-degraded fibrinogen on kinetic parameters of Glu1-plasminogen activation. Biochemistry (1988) 0.84
Directed migration of murine and human tumor cells to collagenases and other proteases. Cancer Res (1989) 0.83
Plasminogen activators in human malignant melanoma. J Natl Cancer Inst (1984) 0.83
A virgin enzyme derived from human plasminogen. Specific cleavage of the arginyl-560-valyl peptide bond in the diisopropoxyphosphinyl virgin enzyme by plasminogen activators. Biochemistry (1982) 0.82
Secretion of plasminogen activators by human colorectal and gastric tumor explants. Clin Exp Metastasis (1988) 0.82
Ligand-stabilized conformations in serum albumin. J Biol Chem (1967) 0.81
Tryptic hydrolysis of human serum albumin. The pattern of initial fragmentation. J Biol Chem (1967) 0.80
Recombinant human Lys-plasmin and the Lys-plasmin . streptokinase complex. J Biol Chem (1979) 0.80
The human plasmin-derived light (B) chain X streptokinase complex: a second-generation thrombolytic agent. Thromb Haemost (1983) 0.79
Identification of the active-site serine in human lecithin: cholesterol acyltransferase. Arch Biochem Biophys (1988) 0.79
Cancer cells release a covalent complex containing disulfide-linked domains from urinary plasminogen activator, neural cell adhesion molecule, and haptoglobin alpha and beta chains. Arch Biochem Biophys (1997) 0.79
Human plasminogen variant Chicago III. Thromb Haemost (1982) 0.79
Investigation of a congenital abnormal plasminogen, Frankfurt I, and its relationship to thrombosis. Thromb Haemost (1986) 0.78
Augmentation of streptokinase activator activity by fibrinogen or fibrin. Thromb Res (1980) 0.78
Epidermal growth factor and 12-tetradecanoyl phorbol 13-acetate induction of urokinase in A431 cells. Semin Thromb Hemost (1991) 0.77
Potentiation of thrombolytic therapy by enzyme combinations and with aspirin or pentoxifylline. J Med (1994) 0.77
Urokinase secretion from human colon carcinomas induced by endogenous diglycerides. Cancer Res (1990) 0.75
As I see it. Changes offer opportunities, pose risks for nurses. Am Nurse (1987) 0.75
Stroke in a young adult with familial plasminogen disorder. Stroke (1991) 0.75
[Baroreceptor reflexes after exposure to the hypotensive action of prazosin blocking postsynaptic alpha 1-adrenergic receptors]. Kardiologiia (1985) 0.75
Conformational changes in aspartate transcarbamylase. IV. Ligand effects on intersubunit interactions. J Biol Chem (1972) 0.75
Kinetic properties of thymidine kinase from the cytosol of a rat colon adenocarcinoma. J Med (1982) 0.75
Considered approaches to physician payment in the '90s. Nurs Econ (1988) 0.75
Further evidence for an active center in streptokinase-plasminogen complex; interaction with pancreatic trypsin inhibitor. Biochem Biophys Res Commun (1973) 0.75
A new method for plasminogen standardization. Thromb Diath Haemorrh (1968) 0.75
Methods for studying fibrinolytic pathway components in human plasma. Thromb Res (1982) 0.75
Catalytic efficiency of activation of human plasminogen by various activator species. Haemostasis (1978) 0.75
Carbon-13 NMR studies of 13CO binding to human hemoglobin. Biochem Biophys Res Commun (1973) 0.75
Aminocaproic acid (AMICAR) in advanced colorectal carcinoma. J Surg Oncol (1986) 0.75
Plasmin and plasminogen activators: kinetics, and kinetics of plasminogen activation. Ann N Y Acad Sci (1981) 0.75
Plasminogen activator content of gynecological tumors and their metastases. Gynecol Oncol (1987) 0.75
[The inborn ear fistula in the horse]. Dtsch Tierarztl Wochenschr (1974) 0.75
Congenital abnormal plasminogen, Frankfurt I, a cause for recurrent venous thrombosis. Haemostasis (1988) 0.75
Anion-specific effects on the streptokinase activation of human plasminogen. J Biol Chem (1968) 0.75
Characterization of a family of high-molecular-weight plasminogen activators secreted by a lung tumor cell line. Biochim Biophys Acta (1991) 0.75
PPOs: are they good for ASHA members? Task Force on Treatment Outcome and Cost Effectiveness. ASHA (1996) 0.75